Genetic Polymorphisms of the Interleukin-18 Gene and Risk of Prostate Cancer
Authors:
- 1 August 2007
- journal article
- research article
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 26 (8) , 613-618
Abstract
Genetic factors are known to be important in the development of prostate cancer. Interleukin-18 (IL-18) is a multifunctional cytokine that induces interferon-gamma secretion and plays an important role in antitumor immunity. Variations in the DNA sequence in the IL-18 gene promoter may lead to altered IL-18 production and/or activity, and so this can modulate an individual's susceptibility to prostate cancer. To test this hypothesis, we investigated the relationship of IL-18 gene promoter −137 G/C and −607 C/A polymorphisms and their haplotypes with the risk of prostate cancer. We analyzed two single nucleotide polymorphisms of IL-18 gene promoter −137 G/C and −607 C/A in 265 patients with prostate cancer and 280 age- and sex-matched controls, using sequence-specific primers–polymerase chain reaction strategy. There were significant differences in the genotype and allele distribution of −137 G/C polymorphism of the IL-18 gene among cases and controls. The −137 GC and CC genotypes were associated with a significantly increased risk of prostate cancer as compared with the −137 GG genotypes [odds ratio (OR) = 1.721; 95% confidence interval (CI): 1.187–2.496; p = 0.004, and OR = 2.181; 95% CI: 1.034–4.603; p = 0.037, for GC and CC, respectively]. Consistent with the results of the genotyping analyses, the −137C/−607A haplotype was associated with a significantly increased risk of prostate cancer as compared with the −137G/−607C haplotype (OR = 1.544; 95% CI, 1.137–2.096; p = 0.005). This study shows for the first time an association between IL-18 gene promoter −137 G/C polymorphism and prostate cancer in a Chinese population.Keywords
This publication has 28 references indexed in Scilit:
- Diet After Diagnosis and the Risk of Prostate Cancer Progression, Recurrence, and Death (United States)Cancer Causes & Control, 2006
- The common G‐allele of interleukin‐18 single‐nucleotide polymorphism is a genetic risk factor for atopic asthma. The SAPALDIA Cohort StudyClinical & Experimental Allergy, 2006
- Interleukin-18-promoter polymorphisms are not relevant in rheumatoid arthritisTissue Antigens, 2005
- SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism lociCell Research, 2005
- Interleukin IL-18 gene promoter polymorphisms in adult patients with type 1 diabetes mellitus and latent autoimmune diabetes in adultsImmunology Letters, 2005
- Engineered Fusion Hybrid Vaccine of IL-18 Gene-Modified Tumor Cells and Dendritic Cells Induces Enhanced Antitumor ImmunityCancer Biotherapy and Radiopharmaceuticals, 2004
- Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinomaCancer Letters, 2004
- IL‐18 is produced by prostate cancer cells and secreted in response to interferonsInternational Journal of Cancer, 2003
- A New Statistical Method for Haplotype Reconstruction from Population DataThe American Journal of Human Genetics, 2001
- Interleukin-18Methods, 1999